Non-invasive blood glucose monitor develops as Know Labs works with new partners to speed up FDA approval

As it works toward receiving FDA certification for its non-invasive glucose monitoring devices, the KnowU and UBand, Know Labs, the organization responsible for the invention of Bio-RFID technology, has disclosed its many productive alliances. The company now gets support in crucial areas including accelerated product development, machine learning, and FDA clearance. An update on the development of its non-invasive blood glucose monitors, which make use of the company's Bio-RFID technology, has been published by Know Labs (RFID: radio-frequency identification). The FDA clinical studies are the next step before the devices are made available for purchase, and at this time, sensors for the KnowU (accessory) and UBand (wearable) glucose monitors are being tested in human trials. While several businesses have asserted to have already created these important monitors for diabetics weary of painful finger sticking, Know Labs is adamant that they are the "world's first non-invasive glucose monitoring medical devices" with the necessary FDA approval. Photo Credit: NS Medical Devices The future of the KnowU and UBand non-invasive glucose monitors appears to be secure, which is exciting for the millions of individuals who still have to endure checking their blood glucose levels by inserting a needle into their fingertips. In brief, Know Labs has enlisted the aid of the Igor Institute for product development and optimization, Edge Impulse for fine-tuning the algorithms used in the glucose level measurement process, and Bould Design for assistance with industrial design. The full details can be read in the press release posted below. Additionally, Racer Technology, which will produce the KnowU and UBand devices, is collaborating with the business, and NOVUS Management Group has been chosen to assist with speeding growth. Know Labs has provided updates on its development despite the fact that many businesses assert they are just a few steps away from providing comprehensive needle-free and painless solutions for continually measuring blood sugar levels. Although the situation appears promising, Chief Product Officer Steven Kent said in a video regarding internal experiments that "breakthrough technology doesn't make itself" and that "it's going to take time." Currently, tests of Know Labs' Bio-RFID technology have "highly corresponded," according to the company, with results from conventional fingersticking techniques and currently available continuous glucose monitors (CGM). It is evident from the relationships the company has now that there is enough support for Bio-RFID, the KnowU and UB, and non-invasive glucose monitors for the business.